These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2438401

  • 1. Effects of a 5-lipoxygenase inhibitor, REV-5901, on leukotriene and histamine release from human lung tissue in-vitro.
    Tennant CM, Seale JP, Temple DM.
    J Pharm Pharmacol; 1987 Apr; 39(4):309-11. PubMed ID: 2438401
    [Abstract] [Full Text] [Related]

  • 2. Inhibition by REV-5901 of leukotriene release from guinea-pig and human lung tissue in vitro.
    Kusner EJ, Marks RL, Aharony D, Krell RD.
    Biochem Pharmacol; 1989 Dec 01; 38(23):4183-9. PubMed ID: 2557041
    [Abstract] [Full Text] [Related]

  • 3. Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate.
    Salari H, Borgeat P, Fournier M, Hebert J, Pelletier G.
    J Exp Med; 1985 Dec 01; 162(6):1904-15. PubMed ID: 2415659
    [Abstract] [Full Text] [Related]

  • 4. Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.
    Anderson G, Fennessy M.
    Br J Pharmacol; 1988 Aug 01; 94(4):1115-22. PubMed ID: 3145088
    [Abstract] [Full Text] [Related]

  • 5. Myocardial salvage induced by REV-5901: an inhibitor and antagonist of the leukotrienes.
    Mullane K, Hatala MA, Kraemer R, Sessa W, Westlin W.
    J Cardiovasc Pharmacol; 1987 Oct 01; 10(4):398-406. PubMed ID: 2444792
    [Abstract] [Full Text] [Related]

  • 6. Effects of 5-lipoxygenase inhibition on cardiac anaphylaxis in isolated guinea pig hearts.
    Jolly SR, Travis J, Van Inwegen RG.
    Pharmacology; 1989 Oct 01; 38(6):352-62. PubMed ID: 2813496
    [Abstract] [Full Text] [Related]

  • 7. Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists.
    Hughes JM, Seale JP, Temple DM.
    Eur J Pharmacol; 1983 Nov 25; 95(3-4):239-45. PubMed ID: 6197312
    [Abstract] [Full Text] [Related]

  • 8. The effects of non-steroidal inhibitors of phospholipase A2 on leukotriene and histamine release from human and guinea-pig lung.
    Kench JG, Seale JP, Temple DM, Tennant C.
    Prostaglandins; 1985 Aug 25; 30(2):199-208. PubMed ID: 2413502
    [Abstract] [Full Text] [Related]

  • 9. Effects of the new 5-lipoxygenase inhibitor E6080 on leukotriene release in vitro.
    Sakuma Y, Katayama S, Tsunoda H, Abe S, Yamatsu I, Katayama K.
    Int Arch Allergy Immunol; 1992 Aug 25; 97(4):267-73. PubMed ID: 1375926
    [Abstract] [Full Text] [Related]

  • 10. Nedocromil sodium inhibits antigen-induced contraction of human lung parenchymal and bronchial strips, and the release of sulphidopeptide-leukotriene and histamine from human lung fragments.
    Napier FE, Shearer MA, Temple DM.
    Br J Pharmacol; 1990 Jun 25; 100(2):247-50. PubMed ID: 1696152
    [Abstract] [Full Text] [Related]

  • 11. Loratadine, an antihistamine, blocks antigen-and ionophore-induced leukotriene release from human lung in vitro.
    Temple DM, McCluskey M.
    Prostaglandins; 1988 Apr 25; 35(4):549-54. PubMed ID: 2470117
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heterogeneity of human mast cells and basophils. Effects of a putative 5-lipoxygenase inhibitor.
    Cohan V, McKenzie-White J, Triggiani M, Massey W, Kagey-Sobotka A, Lichtenstein LM.
    Biochem Pharmacol; 1989 Dec 15; 38(24):4455-9. PubMed ID: 2481451
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of arachidonic acid metabolism on the release of histamine and SRS (leukotrienes) from guinea-pig lung.
    Chakravarty N.
    Agents Actions; 1984 Apr 15; 14(3-4):429-34. PubMed ID: 6203364
    [Abstract] [Full Text] [Related]

  • 17. The role of arachidonate lipoxygenase in the release of SRS-A from guinea-pig chopped lung.
    Morris HR, Piper PJ, Taylor GW, Tippins JR.
    Prostaglandins; 1980 Mar 15; 19(3):371-83. PubMed ID: 6155680
    [Abstract] [Full Text] [Related]

  • 18. [Effects of the 5-lipoxygenase inhibitor phenidone on antigen-induced release of histamine in vitro].
    Sauer RR, Sauer CI, Merk H, Steigleder GK.
    Z Hautkr; 1987 Aug 01; 62(15):1175-8. PubMed ID: 2445116
    [Abstract] [Full Text] [Related]

  • 19. Preferential inhibition of 5-lipoxygenase activity by manoalide.
    De Vries GW, Amdahl L, Mobasser A, Wenzel M, Wheeler LA.
    Biochem Pharmacol; 1988 Aug 01; 37(15):2899-905. PubMed ID: 2840081
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor.
    Ashida Y, Saijo T, Kuriki H, Makino H, Terao S, Maki Y.
    Prostaglandins; 1983 Dec 01; 26(6):955-72. PubMed ID: 6084855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.